Satellos Bioscience
C$0.48
2
+C$0.01+2.13% Tuesday 16:07
Statistics
Day High
0.48
Day Low
0.48
52W High
0.85
52W Low
0.22
Volume
19,981
Avg. Volume
47,484
Mkt Cap
11.49M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
23NovConfirmed
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.34
-0.23
-0.13
-0.02
Expected EPS
-0.07
Actual EPS
-0.05
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MSCL.V. It's not an investment recommendation.
About
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.
Show more...
CEO
Mr. Francis Gleeson B.B.A. M.B.A
Country
CA
ISIN
CA80401L3083
WKN
000A3CSSM